Literature DB >> 35996631

Subclinical Hypercortisolism: An Important, Unrecognized Dysfunction.

Lara Pizzorno, Joseph Pizzorno.   

Abstract

While Cushing syndrome is rare, but well-recognized, subclinical hypercortisolism (defined as excessive cortisol secretion without the classic manifestations of Cushing syndrome) is significantly more common. Subclinical hypercortisolism contributes to several chronic diseases, such as diabetes, osteoporosis, sarcopenia and hypertension. The incidence increases with age and correlates with body load of environmental toxins such as bisphenol A (BPA). This editorial discusses prevalence, contribution to disease, causes, diagnosis, and intervention.
Copyright © 2022 InnoVision Professional Media Inc.

Entities:  

Year:  2022        PMID: 35996631      PMCID: PMC9380834     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  23 in total

Review 1.  MECHANISMS IN ENDOCRINOLOGY: Endogenous subclinical hypercortisolism and bone: a clinical review.

Authors:  I Chiodini; C Eller Vainicher; V Morelli; S Palmieri; E Cairoli; A S Salcuni; M Copetti; A Scillitani
Journal:  Eur J Endocrinol       Date:  2016-07-13       Impact factor: 6.664

2.  Prenatal exposure to bisphenol A disrupts adrenal steroidogenesis in adult mouse offspring.

Authors:  Samantha Medwid; Haiyan Guan; Kaiping Yang
Journal:  Environ Toxicol Pharmacol       Date:  2016-03-17       Impact factor: 4.860

Review 3.  Do the diagnostic criteria for subclinical hypercortisolism exist?

Authors:  Antoine Tabarin
Journal:  Ann Endocrinol (Paris)       Date:  2018-04-13       Impact factor: 2.478

Review 4.  Vertebral morphometry.

Authors:  Daniele Diacinti; Giuseppe Guglielmi
Journal:  Radiol Clin North Am       Date:  2010-05       Impact factor: 2.303

5.  Differences in the glucuronidation of bisphenols F and S between two homologous human UGT enzymes, 1A9 and 1A10.

Authors:  Darja Gramec Skledar; Johanna Troberg; Jason Lavdas; Lucija Peterlin Mašič; Moshe Finel
Journal:  Xenobiotica       Date:  2014-12-30       Impact factor: 1.908

Review 6.  Adrenocortical endocrine disruption.

Authors:  Philip W Harvey
Journal:  J Steroid Biochem Mol Biol       Date:  2014-10-18       Impact factor: 4.292

7.  Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study.

Authors:  Valentina Morelli; Cristina Eller-Vainicher; Antonio Stefano Salcuni; Francesca Coletti; Laura Iorio; Giovanna Muscogiuri; Silvia Della Casa; Maura Arosio; Bruno Ambrosi; Paolo Beck-Peccoz; Iacopo Chiodini
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

8.  "Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study.

Authors:  Diana Lopez; Miguel Angel Luque-Fernandez; Amy Steele; Gail K Adler; Alexander Turchin; Anand Vaidya
Journal:  Ann Intern Med       Date:  2016-08-02       Impact factor: 25.391

Review 9.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

10.  Nonfunctional adrenal incidentalomas may be related to bisphenol-A.

Authors:  Fatih Eker; Askin Gungunes; Senay Durmaz; Ucler Kisa; Zeynep Rumeysa Celik
Journal:  Endocrine       Date:  2020-09-23       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.